Rituximab levels are associated with the B cell homeostasis but not with the clinical response in patients with rheumatoid arthritis

OBJECTIVE: To study the levels of rituximab (RTX) and anti-RTX antibodies (ARAs) in patients with rheumatoid arthritis (RA) at 30, 90, and 180 days after the first infusion, in relation to clinical and serological parameters and B cell homeostasis. METHODS: Thirty-four patients with RA who failed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Díaz-Torné, Cèsar, Ortiz, Maria Àngels, Sarmiento, Mónica, Díaz-López, César, Corominas, Hèctor, Casademont, Jordi, Vidal, Silvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medical Research and Education Association 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467324/
https://www.ncbi.nlm.nih.gov/pubmed/31365341
http://dx.doi.org/10.5152/eurjrheum.2019.18109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467324/
https://www.ncbi.nlm.nih.gov/pubmed/31365341
http://dx.doi.org/10.5152/eurjrheum.2019.18109

Ejemplares similares